GAITHERSBURG, Maryland, 27. Mai 2023 /PRNewswire/ — Novavax, Inc. Nasdaq: NVAX), ein globales Unternehmen, das Impfstoffe auf Proteinbasis mit seinem neuartigen Matrix-M™-Adjuvans entwickelt, gab heute bekannt, dass Nuvaxovid™ (NVX-CoV2373) in der Europäischen Union (EU) nach einer…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.